SAFC Biosciences provides an integrated services package in mammalian cell culture media development to support customer programs from pre-clinical and clinical development through to commercialization. Analytical and regulatory support is also part of the package to directly benefit speed-to-market times.
Headquartered in Lenexa, Kansas, SAFC Biosciences has six production facilities in the US, Europe and Australia and employs 600 people. Main product lines are EX-CELL serum-free media; serum-based products; LONG growth factors and BIOEAZE disposable bioprocessing systems.
As the basis for its biopharmaceutical expansion program, Sigma-Aldrich acquired JRH Biosciences from Australia's CSL Limited in February 2005 creating SAFC Biosciences.
No reviews to display
07 Mar 2013
08 Jul 2011
SAFC Announces Launch of Raw Materials and Custom Services Developed Specifically for Point-of-Care Diagnostics Manufacture
15 Mar 2011
19 Nov 2009
27 Oct 2006